Loading clinical trials...
Loading clinical trials...
Myotonic Dystrophy type 1 (DM1) is a genetic multisystem disease causing muscle weakness and myotonia. As a result, upper limb function might become impaired. There are little research regarding rehab...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Oslo
Collaborators
NCT06809049 · Myotonic Dystrophy, Congenital, Myotonic Dystrophy, Type 1 (DM1), and more
NCT06708468 · Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), and more
NCT05027269 · DM1, Myotonic Dystrophy 1, and more
NCT04835298 · Myotonic Dystrophy Type 1 (DM1)
Vikersund Rehabilitation Center
Vikersund, Akershus
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions